Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
AXGN | Axogen, Inc. | CEO, Director | $8.78M | -$302K | -3.32% | Mar 16, 2024 |
EYPT | EyePoint Pharmaceuticals, Inc. | Director | $152K | +$99.8K | +190% | Aug 19, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|